Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
J Drugs Dermatol ; 21(6): 677-680, 2022 Jun 01.
Artigo em Inglês | MEDLINE | ID: mdl-35674755

RESUMO

Disparities and inequities exist in dermatological access and outcomes, associated with demographics such as socioeconomic status (SES) and geography. Some studies have documented barriers to care and treatment adherence in dermatology such as financial and insurance challenges, logistical considerations, and sociocultural beliefs.


Assuntos
Dermatologia , Acessibilidade aos Serviços de Saúde , Estudos Transversais , Humanos , Aceitação pelo Paciente de Cuidados de Saúde , Fatores Socioeconômicos
2.
J Drugs Dermatol ; 19(5): 532-538, 2020 May 01.
Artigo em Inglês | MEDLINE | ID: mdl-32484619

RESUMO

BACKGROUND: Many dermatologists consider social media to be a useful tool for building their practices and personal brands. However, limited data exists on patients’ perceptions of the value of social media in dermatology. OBJECTIVE: To examine how social media influences patients when choosing a dermatologist and which aspects of dermatologists’ sites offer the most benefit to patients. METHODS: A cross-sectional study was completed by sampling a diverse online population using a 10-question survey. RESULTS: The survey was sent to 1,481 individuals; of the 57.5% who qualified, 98.5% completed the survey (N=715). Of the qualified respondents, 58% were female and 42% were male. Twenty five percent were 18-29 years, 24% were 30-44 years, 33% were 45-60 years, and 19% were over 60 years. Fifty-seven percent reported that social media is only slightly important or not at all important when selecting a dermatologist. According to respondents, patient reviews (68%), years of experience (61%), and medical information written by the dermatologist (59%) were the most important aspects of dermatologists’ social media sites. Cosmetic patients (P<0.0001), younger patients (P<0.0001), and participants with fewer years of education (P=0.0006) valued social media significantly more when selecting a dermatologist compared to their counterpart populations. LIMITATIONS: Selection bias is possible given the survey was distributed only to SurveyMonkey® users. CONCLUSION: Given the majority of patients reported that social media is not important or only slightly important, dermatologists should consider means other than social media to attract new patients to their practices. For dermatologists who use social media, they should highlight patient reviews, experience level, and original medical content. J Drugs Dermatol. 2020;19(5):   doi:10.36849/JDD.2020.4849.


Assuntos
Dermatologistas/organização & administração , Marketing de Serviços de Saúde/métodos , Preferência do Paciente/estatística & dados numéricos , Mídias Sociais/estatística & dados numéricos , Adolescente , Adulto , Comportamento de Escolha , Estudos Transversais , Dermatologistas/economia , Humanos , Marketing de Serviços de Saúde/estatística & dados numéricos , Pessoa de Meia-Idade , Inquéritos e Questionários/estatística & dados numéricos , Adulto Jovem
3.
Ann Allergy Asthma Immunol ; 122(5): 508-512, 2019 05.
Artigo em Inglês | MEDLINE | ID: mdl-30802503

RESUMO

BACKGROUND: There is a paucity of data on the burden of insurance limitations for patients undergoing patch testing. OBJECTIVE: To characterize the burden of insurance limitations and its impact on differences in management and execution of patch testing. METHODS: A retrospective chart review was performed on patients with a diagnosis of contact dermatitis (International Classification of Disease [ICD], Ninth Edition, code ICD 692) who received patch testing (Current Procedural Terminology code 95044) at the George Washington Medical Faculty Associates Dermatology Clinic between January 1, 2015 and June 30, 2017. Variables including allergen limitations were compared between government-sponsored insurance and private insurance providers (eg, Insurers A, B, C, and D). RESULTS: A total of 371 records were identified. Government-sponsored insurance patients encountered allergen limitations more frequently than private insurance patients (86.8% vs 14.2%, P < .0001). Insurer C and D patients were least likely to encounter allergen limitations (1.2% vs 0%, P < .0001) and were tested to the most allergens (mean = 146 vs 152, P < .0001). Insurer A patients had the least allergens tested among those privately insured. CONCLUSION: Considering modification of insurance policies to allow patch testing with a larger number of allergens without restrictions is needed, with the goal of improving quality of life of these patients while saving costs from chronic use of topical corticosteroids.


Assuntos
Alérgenos/administração & dosagem , Dermatite Alérgica de Contato/diagnóstico , Gastos em Saúde/estatística & dados numéricos , Cobertura do Seguro/estatística & dados numéricos , Testes do Emplastro/economia , Adulto , Dermatite Alérgica de Contato/economia , Dermatite Alérgica de Contato/imunologia , Dermatite Alérgica de Contato/fisiopatologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Qualidade de Vida/psicologia , Estudos Retrospectivos , Pele/efeitos dos fármacos , Pele/imunologia , Pele/fisiopatologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA